(Q34481352)

2 August 2017

title

Efavirenz concentrations in CSF exceed IC50 for wild-type HIV. (English)

1 reference

2 August 2017

1 reference

Ronald Ellis

13

0 references

Igor Grant

series ordinal

14

object named as

Igor Grant

1 reference

2 August 2017

15

CHARTER Group

1 reference

2 August 2017

3

Scott L Letendre

1 reference

2 August 2017

10

J Allen McCutchan

1 reference

2 August 2017

8

Benjamin B Gelman

1 reference

2 August 2017

1

Brookie M Best

1 reference

2 August 2017

9

Gilbert Mbeo

1 reference

2 August 2017

4

Edmund V Capparelli

1 reference

2 August 2017

2

Peter P Koopmans

1 reference

2 August 2017

12

Richard Haubrich

1 reference

2 August 2017

7

Ann C Collier

1 reference

2 August 2017

Steven S Rossi

5

1 reference

2 August 2017

David B Clifford

series ordinal

6

1 reference

2 August 2017

David M Simpson

series ordinal

11

1 reference

2 August 2017

language of work or name

English

0 references

publication date

23 November 2010

1 reference

Journal of Antimicrobial Chemotherapy

2 August 2017

published in

1 reference

2 August 2017

volume

66

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

354-357

1 reference

Natural variation of drug susceptibility in wild-type human immunodeficiency virus type 1

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3019085

Stable concentrations of zidovudine, stavudine, lamivudine, abacavir, and nevirapine in serum and cerebrospinal fluid during 2 years of therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3019085

A randomized controlled trial of therapeutic drug monitoring in treatment-naive and -experienced HIV-1-infected patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3019085

Efficacy of cerebrospinal fluid (CSF)-penetrating antiretroviral drugs against HIV in the neurological compartment: different patterns of phenotypic resistance in CSF and plasma

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3019085

Nevirapine and efavirenz pharmacokinetics and covariate analysis in the 2NN study.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3019085

Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3019085

Cognitive dysfunction in HIV patients despite long-standing suppression of viremia

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3019085

Roundtable Report: Importance of Antiretroviral Drug Concentrations in Sanctuary Sites and Viral Reservoirs

9 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21098541

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/JAC/DKQ434

1 reference

2 August 2017

1 reference

2 August 2017

1 reference